Safety Profile of Baricitinib in Patients With Active Rheumatoid Arthritis With Over 2 Years Median Time in Treatment

Journal of Rheumatology- Canada

doi 10.3899/jrheum.171361.c1

Full Text

Abstract

Available in

Date

Authors

Unknown

Publisher

The Journal of Rheumatology

Related search

Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

Progression of Subclinical Atherosclerosis Over 5 Years in Patients With Early Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

Cotreatment With Methotrexate in Routine Care Patients With Rheumatoid Arthritis Receiving Biological Treatment Yields Better Outcomes Over Time

RMD Open
RheumatologyAllergyImmunology
2019English

Baricitinib: A New Oral Treatment for Rheumatoid Arthritis

Prescriber
Pharmacology
2017English

Trajectories of Physical Activity Over Two Years in Persons With Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2016English

Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment With Abatacept in Patients With Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial

Journal of Rheumatology
RheumatologyAllergyImmunology
2014English

Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study Extension

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis

Postgraduate Medical Journal
Medicine
2000English

Combination Treatment Is Rare in Patients With Rheumatoid Arthritis

BMJ
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy